- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03135288
Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives
July 18, 2019 updated by: Ahmed Mohamed Abbas, Assiut University
Effect of Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives: a Randomized Controlled Trial
Unintended and closely spaced pregnancies are a major public health problem that affects not only the individuals directly involved but also the society indirectly.
It increases the risks of infants with adverse outcomes such as preterm, low birth weight and small for gestational age.
Pregnancy occurring within six months of the last delivery holds a 7.5-fold increased risk for induced abortion, a 3.3-fold increase in miscarriage and a 1.6-fold increased risk of stillbirth.
But, use of contraceptive methods has been shown to reduce unwanted pregnancy, high fertility and maternal mortality rates.
Study Overview
Study Type
Interventional
Enrollment (Actual)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt
- Assiut Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women who deliver a live birth at greater than 28 week's gestation.
- Women desire birth spacing for more than one year
- Women who were holding and /or one of her family hold a cell-phone and accept to receive messages and phone calls to remind her with her contraceptive program
Exclusion Criteria:
- Women who refuse to participate in the study.
- Women aren't able to respond to the questionnaire due to their health status.
- Anticipation of difficulty of subsequent communication with the women
- Women with contraindications of using long acting reversible contraception ( contraindicated if intrauterine device or implant use)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cell-phone assisted
will be advised that they are going to receive a reminder of their postpartum family planning visit 5 weeks after the delivery (one week before the scheduled visit) and a phone call 48 hours before the scheduled visit.
They will also receive two follow-up phone calls to answer any questions and to remind them with the follow-up visits after insertion.
Woman will be given a referral card to the outpatients' family planning clinic denoting her study group and serial number and with a specific date for postpartum family planning visits.
They will be also provided with a cell phone number working 7 days a week to answer any query or questions regarding her family planning program.
|
a reminder of their postpartum family planning visit 5 weeks after the delivery (one week before the scheduled visit) and a phone call 48 hours before the scheduled visit.
They will also receive two follow-up phone calls to answer any questions and to remind them with the follow-up visits after insertion.
Woman will be given a referral card to the outpatients' family planning clinic denoting her study group and serial number and with a specific date for postpartum family planning visits.
|
|
No Intervention: control group
will receive the same above adequate counseling with referral card but without any phone assistance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Initiation of Long acting reversible contraception method
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
- Shaaban OM, Saber T, Youness E, Farouk M, Abbas AM. Effect of a mobile phone-assisted postpartum family planning service on the use of long-acting reversible contraception: a randomised controlled trial. Eur J Contracept Reprod Health Care. 2020 Aug;25(4):264-268. doi: 10.1080/13625187.2020.1764528. Epub 2020 May 21.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2017
Primary Completion (Actual)
March 15, 2019
Study Completion (Actual)
April 15, 2019
Study Registration Dates
First Submitted
April 27, 2017
First Submitted That Met QC Criteria
April 27, 2017
First Posted (Actual)
May 1, 2017
Study Record Updates
Last Update Posted (Actual)
July 19, 2019
Last Update Submitted That Met QC Criteria
July 18, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- CP-LARC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Family Planning
-
Assiut UniversityNot yet recruiting
-
RANDMakerere UniversityNot yet recruitingFamily Planning
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
University of California, San DiegoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Jacaranda HealthHarvard School of Public Health (HSPH); Jhpiego; IPSOSRecruitingPostpartum Family PlanningKenya
-
Saint-Joseph UniversityRecruitingFamily Planning ServicesLebanon
-
Inonu UniversityThe Scientific and Technological Research Council of TurkeyCompletedFamily PlanningTurkey
-
Boston UniversityUnited States Agency for International Development (USAID); Pharmaceutical...Completed
-
Addis Ababa UniversityUnknown
-
University of California, San FranciscoPopulation Services InternationalCompleted
Clinical Trials on Cell-phone
-
Walter Reed Army Medical CenterAffinity Networks, Inc.UnknownDiabetes MellitusUnited States
-
Aliaa Rehan YoussefCompletedNeck Pain | Cervical PainEgypt
-
Lata Medical Research Foundation, NagpurUnknownMalnutrition in Pregnancy | Other Disorders of Breast and Lactation Associated With ChildbirthIndia
-
Children's Hospital Los AngelesNot yet recruiting
-
Instituto Cardiovascular de Buenos AiresUnknown
-
Jordi Gol i Gurina FoundationPreventive Services and Health Promotion Research NetworkUnknownSmoking CessationSpain
-
Yale UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
National Taiwan University HospitalCompleted
-
University of PennsylvaniaCompleted
-
University of British ColumbiaBritish Columbia Cancer AgencyUnknownLatent Tuberculosis InfectionCanada